HYSPAN 400MG ORAL POWDER

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

NEOMYCIN SULFATE

Mevcut itibaren:

Cross Vetpharm Group Limited

ATC kodu:

QA07AA01

INN (International Adı):

NEOMYCIN SULFATE

Doz:

400 Milligram

Farmasötik formu:

Oral Powder

Reçete türü:

POM

Terapötik grubu:

Bovine

Terapötik alanı:

Neomycin

Terapötik endikasyonlar:

Antibacterial

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2007-01-22

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Hyspan 400mg Oral Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100g sachet contains:
ACTIVE SUBSTANCE
Neomycin Sulphate
400mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral powder.
White to off-white free-flowing powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of scour in calves mainly due to Escherichia coli and Salmonella. Specially formulated to combat
infection, dehydration and loss of electrolytes.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Withdraw all milk and milk replacer from scouring animals.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 06/09/2012_
_CRN 7013315_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Withdraw all milk and milk replacer from scouring animals.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy
should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None known.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration.
For calves between 35 – 75 kg, 5 sachets are required.
Ad